Novel Antivirals for Hepatitis C Novel Antivirals for Hepatitis C
This review spotlights two novel pangenotypic regimens for HCV infection, SOF/VEL/VOX for patients previously treated with NS5A inhibitors, and G/P for patients with advanced kidney disease.Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Drugs & Pharmacology | Gastroenterology | Health | Hepatitis | Hepatitis C | Urology & Nephrology